Literature DB >> 24653620

Intraperitoneal chemotherapy and its evolving role in management of gastric cancer with peritoneal metastases.

Emel Canbay1, Yutaka Yonemura1, Bjorn Brucher1, Seung Hyuk Baik1, Paul H Sugarbaker1.   

Abstract

Advanced gastric cancer (GC) has been recognized as lethal disease when peritoneal metastases (PM) occurred. There is no standard treatment for advanced GC with PM. Until 1980s, the therapeutic arena for these patients had remained stagnant, with no therapeutic approach having shown a survival gain in GC with PM. However, cytoreductive surgery (CRS) with peritonectomy procedures and intraperitoneal chemotherapy (IPC) promising new combined therapeutic approach to achieve disease control for GC with PM. The recent publications changed the GC with PM treatment landscape by providing an evidence that CRS and IPC led to prolongation in overall survival (OS). This review will provide an overview of the evolving role of CRS and IPC in the management of advanced GC with PM in the current era.

Entities:  

Keywords:  Gastric cancer (GC); cytoreductive surgery (CRS); hyperthermic intraperitoneal chemotherapy (IPC); intraperitoneal and systemic induction chemotherapy; peritoneal carcinomatosis

Year:  2014        PMID： 24653620      PMCID： PMC3937744          DOI： 10.3978/j.issn.1000-9604.2014.02.06

Source DB:  PubMed          Journal:  Chin J Cancer Res        ISSN： 1000-9604            Impact factor:   5.087


  17 in total

1.  Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy.

Authors:  Olivier Glehen; François Noel Gilly; Catherine Arvieux; Eddy Cotte; Florent Boutitie; Baudouin Mansvelt; Jean Marc Bereder; Gérard Lorimier; François Quenet; Dominique Elias
Journal:  Ann Surg Oncol       Date:  2010-03-25       Impact factor: 5.344

2.  Improved mortality rate of gastric carcinoma patients with peritoneal carcinomatosis treated with intraperitoneal hyperthermic chemoperfusion combined with surgery.

Authors:  S Fujimoto; M Takahashi; T Mutou; K Kobayashi; T Toyosawa; E Isawa; M Sumida; H Ohkubo
Journal:  Cancer       Date:  1997-03-01       Impact factor: 6.860

3.  Outcome data of patients with peritoneal carcinomatosis from gastric origin treated by a strategy of bidirectional chemotherapy prior to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a single specialized center in Japan.

Authors:  Emel Canbay; Akiyoshi Mizumoto; Masumi Ichinose; Haruaki Ishibashi; Shouzou Sako; Masamitsu Hirano; Nobuyuki Takao; Yutaka Yonemura
Journal:  Ann Surg Oncol       Date:  2013-12-20       Impact factor: 5.344

Review 4.  Effective therapy for peritoneal dissemination in gastric cancer.

Authors:  Yutaka Yonemura; Etsurou Bandou; Kazuo Kinoshita; Taiichi Kawamura; Shigeru Takahashi; Yoshio Endou; Takuma Sasaki
Journal:  Surg Oncol Clin N Am       Date:  2003-07       Impact factor: 3.495

5.  Intraperitoneal hyperthermic perfusion combined with surgery effective for gastric cancer patients with peritoneal seeding.

Authors:  S Fujimoto; R D Shrestha; M Kokubun; M Ohta; M Takahashi; K Kobayashi; S Kiuchi; K Okui; T Miyoshi; N Arimizu
Journal:  Ann Surg       Date:  1988-07       Impact factor: 12.969

6.  Resectable gastric carcinoma. An evaluation of preoperative and postoperative chemotherapy.

Authors:  J A Ajani; D M Ota; J M Jessup; F C Ames; C McBride; A Boddie; B Levin; D E Jackson; M Roh; D Hohn
Journal:  Cancer       Date:  1991-10-01       Impact factor: 6.860

7.  Hyperthermo-chemotherapy combined with cytoreductive surgery for the treatment of gastric cancer with peritoneal dissemination.

Authors:  Y Yonemura; T Fujimura; S Fushida; S Takegawa; T Kamata; K Katayama; T Kosaka; A Yamaguchi; K Miwa; I Miyazaki
Journal:  World J Surg       Date:  1991 Jul-Aug       Impact factor: 3.352

8.  Cytoreductive surgery and intraperitoneal chemohyperthermia for peritoneal carcinomatosis arising from gastric cancer.

Authors:  O Glehen; V Schreiber; E Cotte; A C Sayag-Beaujard; D Osinsky; G Freyer; Y François; J Vignal; F N Gilly
Journal:  Arch Surg       Date:  2004-01

9.  Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for advanced gastric cancer.

Authors:  Jason J Hall; Brian W Loggie; Perry Shen; Staci Beamer; L Douglas Case; Richard McQuellon; Kim R Geisinger; Edward A Levine
Journal:  J Gastrointest Surg       Date:  2004 May-Jun       Impact factor: 3.452

10.  Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial.

Authors:  Xiao-Jun Yang; Chao-Qun Huang; Tao Suo; Lie-Jun Mei; Guo-Liang Yang; Fu-Lin Cheng; Yun-Feng Zhou; Bin Xiong; Yutaka Yonemura; Yan Li
Journal:  Ann Surg Oncol       Date:  2011-03-23       Impact factor: 5.344
View more
  8 in total

Review 1.  Oligometastatic Disease in the Peritoneal Space with Gastrointestinal Cancer.

Authors:  Beate Rau; Andreas Brandl; Andreas Pascher; Wieland Raue; Paul Sugarbaker
Journal:  Visc Med       Date:  2017-02-10

2.  Depletion of mucin in mucin-producing human gastrointestinal carcinoma: Results from in vitro and in vivo studies with bromelain and N-acetylcysteine.

Authors:  Afshin Amini; Samar Masoumi-Moghaddam; Anahid Ehteda; Winston Liauw; David L Morris
Journal:  Oncotarget       Date:  2015-10-20

3.  Whole-exome sequencing to identify somatic mutations in peritoneal metastatic gastric adenocarcinoma: A preliminary study.

Authors:  Hao Liu; Fengping Li; Yu Zhu; Tingting Li; Haipeng Huang; Tian Lin; Yanfeng Hu; Xiaolong Qi; Jiang Yu; Guoxin Li
Journal:  Oncotarget       Date:  2016-07-12

4.  Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in seven patients with peritoneal sarcomatosis from uterine sarcoma.

Authors:  Armando Sardi; Carlos A Muñoz-Zuluaga; Michelle Sittig; Teresa Diaz-Montes
Journal:  Clin Case Rep       Date:  2018-05-02

5.  Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy for Management of Peritoneal Sarcomatosis: A Preliminary Single-Center Experience from Saudi Arabia.

Authors:  Ahmed Abu-Zaid; Ayman Azzam; Mohammed Abuzaid; Tusneem Elhassan; Naryman Albadawi; Lynn Alkhatib; Osama AlOmar; Abdullah Alsuhaibani; Tarek Amin; Ismail A Al-Badawi
Journal:  Gastroenterol Res Pract       Date:  2016-04-24       Impact factor: 2.260

6.  Hyperthermic intraperitoneal chemotherapy combined with systemic chemotherapy for gastric cancer peritoneal carcinomatosis: A protocol for systematic review and meta-analysis of randomized controlled trials.

Authors:  Yidan Lu; Zheng Jin; Song Zheng; Yurong Bai; Yangcheng Sun
Journal:  Medicine (Baltimore)       Date:  2020-07-02       Impact factor: 1.817

Review 7.  Hyperthermic Intraperitoneal Chemotherapy in the Management of Gastric Cancer: A Narrative Review.

Authors:  Marek Mazurek; Małgorzata Szlendak; Alicja Forma; Jacek Baj; Ryszard Maciejewski; Giandomenico Roviello; Luigi Marano; Franco Roviello; Karol Polom; Robert Sitarz
Journal:  Int J Environ Res Public Health       Date:  2022-01-07       Impact factor: 3.390

8.  Is the blood of a surgeon performing HIPEC contaminated by irinotecan, its major metabolites and platinum compounds?

Authors:  Guillaume Saint-Lorant; Simon Rodier; Jean-Marc Guilloit; Sophie Ndaw; Mathieu Melczer; Stéphanie Lagadu; Agnès Palix; Raphaël Delépée
Journal:  Pleura Peritoneum       Date:  2021-03-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.